Ark Therapeutics

Last updated: 13.02.2014

Address: 4th Floor 44-46 Whitfield Street London W1T 2RJ,United Kingdom

Tel: +44 (0) 20 7388 7722


Company description

Ark Therapeutics Group plc is an innovative gene-based medicine company with operations in the UK and Finland. Ark seeks to capitalize on its pipeline of programs in high value areas of unmet medical need within vascular disease and cancer Ark has also developed a small molecule platform based on its acknowledged leadership in vascular biology and is currently working on an exciting NRP-1 antagonist program which is already the subject of interest from major pharmaceutical companies.

Products and services

Ark is distinguished by:
• Development products addressing clear, unmet needs
• Highly valuable GMP manufacturing expertise, characterized by a proven expertise in chemistry and manufacturing control and development of biological in approved facilities.
• Broad follow-on preclinical portfolio – Ark’s founding scientists have acknowledged world-renowned expertise in vascular biology and molecular medicine.


We use cookies to ensure that we give you the best experience on our site. For more info click here